Education
- Fellowship in Blood and Marrow Transplantation
Baylor University Medical Center, Dallas, TX
- Fellowship in Medical Oncology
Scott & White Healthcare and Texas A&M Health Science Center College of Medicine, Temple, TX
- Residency in Internal Medicine
Scott & White Healthcare and Texas A&M Health Science Center College of Medicine, Temple, TX
- Medical Doctorate
Texas Tech University Health Sciences Center, Lubbock, TX
Accolades & Memberships
- American Society for Transplantation and Cellular Therapy
- American Society of Clinical Oncology
- American Society of Hematology
Dr. Reynolds is the Associate Medical Director for Blood & Marrow Transplant Services at Baylor University Medical Center. In 2023, she was named by her peers to the Super Doctors® Rising StarsSM list for the fourth year in a row. Additionally, Dr. Reynolds serves as an adjunct Assistant Professor for the Texas A&M Health Sciences Center College of Medicine.
Procedures
- Bone Marrow Transplant
- Autologous stem cell transplant
- Allogeneic stem cell transplant
- Chimeric Antigen T-Cell Receptor (CAR-T) Therapy
Why a patient should choose treatment at your practice?
Cancer care is a team effort. I am proud of our fantastic care team, from the patient advocate at the front desk to the nurses who infuse your medication. I believe you will find that our team’s love for what they do is evident. We are privileged to enjoy deep relationships with our patients and their families.
What is your personal philosophy around patient care?
Cancer treatment is a journey. I am honored to engage in that journey with my patients. I focus on providing information my patients can understand. I want them to feel empowered so that together WE can make the best possible treatment decisions throughout their care.
Publications
-
Randomized Controlled Trial of Individualized Treatment Summary and Survivorship Care Plans for Hematopoietic Cell Transplantation Survivors
Haematologica, 2019
-
Long-term Outcomes Among 2-year Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Diffuse Large B-Cell Lymphoma
Cancer, 2018
-
Individualized Treatment Summaries and Survivorship Care Plans for Hematopoietic Cell Transplant Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study
American Society of Hematology, Annual Meeting, 2017
-
Adaptation of an Evidence-based Physical Activity Intervention, Fit & Strong!, Promotes Physical Activity and Well Being in Older Cancer Survivors
Frontiers in Public Health, 2015
Show less publications